To be hosted by the U.S. Food and Drug Administration (FDA), the first in a set of five annual conferences is aimed at providing educational sessions for stakeholders interested in learning about the new animal drug approval process. Over the next four years, the FDA will tackle topics centered on the Animal Drug User Fee Act (ADUFA).
Signed into law in 2003, the ADUFA, authorizes the FDA to collect fees for certain new animal drug applications, products, establishments, and sponsors, with the goal to aid the agency in protecting and promoting human and animal health through an enhanced drug review process. In its most recent amendment last year, the ADUFA has authorized the FDA to collect user fees through fiscal year 2028, with performance goals and procedure outlined in a document. Among other objectives, the document requires the agency to hold triannual meetings (three per year) with Animal Health Institute (AHI) members. Annually, one of these meetings will include an educational conference of up to eight hours for the animal drug industry, which will be open to the public.
The inaugural public meeting will be held on July 17, 2024, 9 a.m. to 5 p.m. EST, at the FDA White Oak Campus, 10903 New Hampshire Ave., Bldg. 31 Great Room Conference Center, Silver Spring, MD 20993–0002. Attendees may also join virtually.
For more information, visit the FDA’s Center for Veterinary Medicine (CVM) webpage.